[Antimicrobial therapy for patients with HIV infection].
Koibuchi
Tomohiko
T
Iwamoto
Aikichi
A
D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D019072:Antibiotic Prophylaxis; D023241:Antiretroviral Therapy, Highly Active; D000998:Antiviral Agents / Q000008:administration & dosage; D015496:CD4-Positive T-Lymphocytes; D003586:Cytomegalovirus Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000191:economics / Q000517:prevention & control; D003937:Diagnosis, Differential; D015658:HIV Infections / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D015270:Mycobacterium avium-intracellulare Infection / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control; D009894:Opportunistic Infections / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control; D011020:Pneumonia, Pneumocystis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control; D014376:Tuberculosis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control; D014777:Virus Diseases / Q000150:complications* / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D000998:Antiviral Agents